PANews reported on October 13 that according to Businesswire, Nasdaq-listed company ENDRA Life Sciences announced that it has signed a securities purchase agreement. Investors agreed to subscribe for 744,340 shares of common stock and accompanying warrants to purchase up to 1,488,680 shares of common stock. If all warrants are exercised, the company will raise US$14.4 million to support its digital asset treasury. ENDRA Life Sciences previously disclosed that it will implement a Bitcoin-based revenue-generating strategy.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact
[email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.